Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
3.080
+0.010 (0.33%)
At close: Dec 20, 2024, 4:00 PM
3.230
+0.150 (4.87%)
After-hours: Dec 20, 2024, 7:51 PM EST

Curis Revenue

Curis had revenue of $2.93M in the quarter ending September 30, 2024, with 3.46% growth. This brings the company's revenue in the last twelve months to $10.26M, up 0.44% year-over-year. In the year 2023, Curis had annual revenue of $10.02M, down -1.37%.

Revenue (ttm)
$10.26M
Revenue Growth
+0.44%
P/S Ratio
1.75
Revenue / Employee
$209,367
Employees
49
Market Cap
26.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.02M-139.00K-1.37%
Dec 31, 202210.16M-487.00K-4.57%
Dec 31, 202110.65M-186.00K-1.72%
Dec 31, 202010.84M831.00K8.31%
Dec 31, 201910.00M-424.00K-4.07%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HOOKIPA Pharma 50.00M
DURECT 8.59M
LAVA Therapeutics 7.35M
Daré Bioscience 1.88M
Adagio Medical Holdings 543.00K
Gelteq 95.62K
Revenue Rankings